A Randomized Intervention of Montelukast for Post-Bronchiolitis: Effect on Eosinophil Degranulation

Journal of Pediatrics

Volumn 156, Issue 5, 2010, Pages 749-754

  Kim, Chang Keun ^a   Choi, Jungi ^a   Kim, Hyo Bin ^a   Callaway, Zak ^a   Shin, Bo Moon ^a   Kim, Jin Tack ^b   Fujisawa, Takao ^c   Koh, Young Yull ^d  

^a Inje University College of Medicine   (South Korea)

^b Catholic University Uijongbu St Mary's Hospital   (South Korea)

^c MIE NATIONAL HOSPITAL   (Japan)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL PROTEIN X; MONTELUKAST; PLACEBO;

ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGRANULATION; EOSINOPHIL; FEMALE; FOLLOW UP; HOSPITALIZED INFANT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT DURATION; WHEEZING;

ACETATES; ACUTE DISEASE; BRONCHIOLITIS, VIRAL; CELL DEGRANULATION; DOUBLE-BLIND METHOD; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HUMANS; INFANT; QUINOLINES; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 77950520359     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.12.001     Document Type: Article

References (29)

1. Pullan C.R., and Hey E.N. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J 284 (1982) 1665-1669
2. Frischer T., Halmerbauer G., Gartner C., Rath R., Tauber E., Schierl M., et al. Eosinophil-derived proteins in nasal lavage fluid of neonates of allergic parents and the development of respiratory symptoms during the first 6 months of life. Allergy 55 (2000) 773-777
3. Moqbel R., Lace P., Adamko D.J., and Odemuyiwa S.O. Biology of eosinophils. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Allergy: principles & practice (2008), Mosby, St. Louis 295-310
4. Colocho Zelaya E.A., Orvell C., and Strannegard O. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr Allergy Immunol 5 (1994) 100-106
5. Harrison A.M., Bonville C.A., Rosenberg H.F., and Domachowske J.B. Respiratory syncytial virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 159 (1999) 1918-1924
6. Ehlenfield D.R., Cameron K., and Welliver R.C. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 105 (2000) 79-83
7. Venge P. Monitoring the allergic inflammation. Allergy 59 (2004) 26-32
8. Kim K.W., Lee K.E., Kim E.S., Song T.W., Sohn M.H., and Kim K.E. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung 185 (2007) 97-103
9. Yu J., Yoo Y., Kim D.K., Kang H., and Koh Y.Y. Bronchial responsiveness and serum eosinophil cationic protein levels in preschool children with recurrent wheezing. Ann Allergy Asthma Immunol 94 (2005) 686-692
10. Pifferi M., Ragazzo V., Caramella D., and Baldini G. Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr Pulmonol 31 (2001) 419-424
11. Koller D.Y., Halmerbauer G., Frischer T., and Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?. Clin Exp Allergy 29 (1999) 786-793
12. Taniuchi S., Chihara J., Kojima T., Yamamoto A., Sasai M., and Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 26 (2001) 79-82
13. Da Dalt L., Callegaro S., Carraro S., Andreola B., Corradi M., and Baraldi E. Nasal lavage leukotrienes in infants with RSV bronchiolitis. Pediatr Allergy Immunol 18 (2007) 100-104
14. Volovitz B., Welliver R.C., De Castro G., Krystofik D.A., and Ogra P.L. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 24 (1988) 504-507
15. Bisgaard H., and Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 167 (2003) 379-383
16. Bisgaard H., Flores-Nunez A., Goh A., Azimi P., Halkas A., Malice M.P., et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 178 (2008) 854-860
17. Kim C.K., Koh J.Y., Han T.H., Kim D.K., Kim B.I., and Koh Y.Y. Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis. Acta Paediatrica 95 (2006) 479-485
18. Obase Y., Shimoda T., Tomari S.Y., Mitsuta K., Kawano T., Matsuse H., et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest 121 (2002) 143-150
19. Everard M.L. Acute bronchiolitis and croup. Pediatr Clin North Am 56 (2009) 119-133
20. Parkin P.C., Macarthur C., Saunders N.R., Diamond S.A., and Winders P.M. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 49 (1996) 821-825
21. Papadopoulos N.G., Papi A., Meyer J., Stanciu L.A., Salvi S., Holgate S.T., et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 31 (2001) 1060-1066
22. Tsuji K., Yamamoto S., Ou W., Nishi N., Kobayashi I., Zaitsu M., et al. dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells. Eur Respir J 26 (2005) 795-803
23. Choi E.H., Lee H.J., Yoo T., and Chanock S.J. A common haplotype of interleukin-4 IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 186 (2002) 1207-1211
24. Rosenberg H.F., and Domachowske J.B. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70 (2001) 691-698
25. Kristjansson S., Wennergren D., Eriksson B., Thorarinsdottir H., and Wennergren G. U-EPX levels and wheezing in infants and young children with and without RSV bronchiolitis. Respir Med 100 (2006) 878-883
26. Gleich G.J., and Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol 39 (1986) 177-253
27. Amirav I., Luder A.S., Kruger N., Borovitch Y., Babai I., Miron D., et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics 122 (2008) e1249-e1255
28. Garofalo R., Kimpen J.L., Welliver R.C., and Ogra P.L. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus. J Pediatr 120 (1992) 28-32
29. Abu-Ghazaleh R.I., Dunnette S.L., Loegering D.A., Checkel J.L., Kita H., Thomas L.L., et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 52 (1992) 611-618